PA-25-253-Full-Announcement.html

This document is a Funding Opportunity Announcement (FOA) for the Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) program. The FOA encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control, including modifying behavior, screening, understanding etiological factors, and developing ways to control cancer. The overarching goal is to support early-stage research efforts on novel scientific ideas that have the potential to advance population-based cancer research. The eligible applicant types include for-profit organizations, higher education institutions (private and public), nonprofits, tribal organizations, small businesses, and government entities. The funding is provided by the National Institutes of Health (NIH) under the Cancer Cause and Prevention Research (CFDA 93.393) and Cancer Control (CFDA 93.399) grant programs.